Cargando…

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the position statement of the Korean Diabetes Association 2017 for pharmacological therapy. Many randomized clinical trials and systemat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun Jin, Park, Seok O, Ko, Seung-Hyun, Rhee, Sang Youl, Hur, Kyu-Yeon, Kim, Nan-Hee, Moon, Min Kyong, Lee, Byung-Wan, Kim, Jin Hwa, Choi, Kyung Mook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741550/ https://www.ncbi.nlm.nih.gov/pubmed/29272081 http://dx.doi.org/10.4093/dmj.2017.41.6.423

Ejemplares similares

Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017)

Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017)

Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Monotherapy in patients with type 2 diabetes mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement
por: Oh, Tae Jung, et al.
Publicado: (2020)

Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
por: Oh, Tae Jung, et al.
Publicado: (2020)

Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
por: Yang, Ye Seul, et al.
Publicado: (2023)

Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
por: Yang, Ye Seul, et al.
Publicado: (2023)

Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
por: Hur, Kyu Yeon, et al.
Publicado: (2020)

Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
por: Hur, Kyu Yeon, et al.
Publicado: (2020)

2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
por: Choi, Jong Han, et al.
Publicado: (2023)

Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
por: Lee, Kyu-Sun, et al.
Publicado: (2023)

Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
por: Lee, Kyu-Sun, et al.
Publicado: (2023)

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2023)

Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022
por: Lee, Kyung Ae, et al.
Publicado: (2022)

Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management: consensus statement of the Korean Society for the Study of obesity, Korean Diabetes Association, and Korean Society of Hypertension
por: Choi, Jong Han, et al.
Publicado: (2022)

Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension
por: Choi, Jong Han, et al.
Publicado: (2022)

Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension
por: Choi, Jong Han, et al.
Publicado: (2022)

Prevalence of Chronic Complications in Korean Patients with Type 2 Diabetes Mellitus Based on the Korean National Diabetes Program
por: Rhee, Sang Youl, et al.
Publicado: (2011)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
por: Lee, Byung-Wan, et al.
Publicado: (2020)

2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
por: Kim, Mee Kyoung, et al.
Publicado: (2019)

Familial Clustering of Type 2 Diabetes in Korean Women with Gestational Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2010)

2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
por: Hur, Kyu Yeon, et al.
Publicado: (2021)

The Incretins and Pancreatic β-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus
por: Kim, Mi-Hyun, et al.
Publicado: (2010)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
por: Kim, So Ra, et al.
Publicado: (2013)

A Genome-Wide Association Study of Gestational Diabetes Mellitus in Korean Women
por: Kwak, Soo Heon, et al.
Publicado: (2012)

Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
por: Baek, Jong Ha, et al.
Publicado: (2022)

Arsenic Exposure and Prevalence of Diabetes Mellitus in Korean Adults
por: Rhee, Sang Youl, et al.
Publicado: (2013)

The molecular pharmacology of glucagon agonists in diabetes and obesity
por: Novikoff, Aaron, et al.
Publicado: (2023)

Diabetes Status and Association With Risk of Tuberculosis Among Korean Adults
por: Yoo, Jung Eun, et al.
Publicado: (2021)

Evaluation of Stress in Korean Patients with Diabetes Mellitus Using the Problem Areas in Diabetes-Korea Questionnaire
por: Eom, Young Sil, et al.
Publicado: (2011)

Korean Type 2 Diabetes Patients have Multiple Adenomatous Polyps Compared to Non-diabetic Controls
por: Suh, Sunghwan, et al.
Publicado: (2011)

Importance of family history of diabetes in computing a diabetes risk score in Korean prediabetic population
por: Ustulin, Morena, et al.
Publicado: (2018)

Factors Associated for Mild Cognitive Impairment in Older Korean Adults with Type 2 Diabetes Mellitus
por: Lee, Yun Jeong, et al.
Publicado: (2014)

HLA and Insulin-Dependent Diabetes Mellitus in Koreans()
por: Rhee, Byoung Doo, et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_ag7rcqn1pm8ciiatphri50nn5a